每日一次服用烟酸/氯吡格雷对3期血脂异常慢性肾脏病患者的持续低磷血症作用。 - Suppr

Suppr

超能文献

Sustained hypophosphatemic effect of once-daily niacin/laropiprant in dyslipidemic CKD stage 3 patients.

作者信息

Ix Joachim H, Ganjoo Prerna, Tipping Diane, Tershakovec Andrew M, Bostom Andrew G

出版信息

Am J Kidney Dis. 2011 Jun;57(6):963-5. doi: 10.1053/j.ajkd.2011.03.010. Epub 2011 Apr 15.

DOI:10.1053/j.ajkd.2011.03.010

PMID:21496982

Abstract

摘要

相似文献

Sustained hypophosphatemic effect of once-daily niacin/laropiprant in dyslipidemic CKD stage 3 patients.

Am J Kidney Dis. 2011 Jun;57(6):963-5. doi: 10.1053/j.ajkd.2011.03.010. Epub 2011 Apr 15.

Safety of extended-release niacin/laropiprant in patients with dyslipidemia.

J Clin Lipidol. 2010 Mar-Apr;4(2):105-112.e1. doi: 10.1016/j.jacl.2010.02.002. Epub 2010 Feb 12.

Efficacy and safety of extended-release niacin/laropiprant plus statin vs. doubling the dose of statin in patients with primary hypercholesterolaemia or mixed dyslipidaemia.

Int J Clin Pract. 2010 May;64(6):727-38. doi: 10.1111/j.1742-1241.2010.02370.x.

Hypophosphatemic effect of niacin in patients without renal failure: a randomized trial.

Clin J Am Soc Nephrol. 2010 Apr;5(4):582-9. doi: 10.2215/CJN.07341009. Epub 2010 Mar 18.

Efficacy and tolerability of extended-release niacin/laropiprant in dyslipidemic patients with metabolic syndrome.

J Clin Lipidol. 2010 Nov-Dec;4(6):515-21. doi: 10.1016/j.jacl.2010.08.020. Epub 2010 Oct 28.

Extended-release niacin with laropiprant : a review on efficacy, clinical effectiveness and safety.

Expert Opin Pharmacother. 2012 Jun;13(9):1345-62. doi: 10.1517/14656566.2012.690395.

Extended-release niacin/laropiprant lowers serum phosphorus concentrations in patients with type 2 diabetes.

J Clin Lipidol. 2011 Jul-Aug;5(4):281-7. doi: 10.1016/j.jacl.2011.03.455. Epub 2011 May 13.

Extended-release niacin/laropiprant: reducing niacin-induced flushing to better realize the benefit of niacin in improving cardiovascular risk factors.

Cardiol Clin. 2008 Nov;26(4):547-60. doi: 10.1016/j.ccl.2008.06.007.

Safety and tolerability of extended-release niacin with laropiprant.

Expert Opin Drug Saf. 2012 Jan;11(1):151-9. doi: 10.1517/14740338.2011.638281. Epub 2011 Dec 1.

Dyslipidaemia: Failure to THRIVE: the end for niacin?

Nat Rev Cardiol. 2013 May;10(5):246-7. doi: 10.1038/nrcardio.2013.48. Epub 2013 Apr 2.

引用本文的文献

Effects of Nicotinamide and Lanthanum Carbonate on Serum Phosphate and Fibroblast Growth Factor-23 in CKD: The COMBINE Trial.

J Am Soc Nephrol. 2019 Jun;30(6):1096-1108. doi: 10.1681/ASN.2018101058. Epub 2019 May 13.

The effect of chronic kidney disease on lipid metabolism.

Int Urol Nephrol. 2019 Feb;51(2):265-277. doi: 10.1007/s11255-018-2047-y. Epub 2018 Dec 5.

More than skin deep? Potential nicotinamide treatment applications in chronic kidney transplant recipients.

World J Transplant. 2016 Dec 24;6(4):658-664. doi: 10.5500/wjt.v6.i4.658.

Nicotinamide and phosphate homeostasis in chronic kidney disease.

Curr Opin Nephrol Hypertens. 2016 Jul;25(4):285-91. doi: 10.1097/MNH.0000000000000236.

Phosphate and FGF-23 homeostasis after kidney transplantation.

Nat Rev Nephrol. 2015 Nov;11(11):656-66. doi: 10.1038/nrneph.2015.153. Epub 2015 Sep 29.

Epidemiologic insights on the role of fibroblast growth factor 23 in cardiovascular disease.

Curr Opin Nephrol Hypertens. 2015 May;24(3):260-7. doi: 10.1097/MNH.0000000000000123.

Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD.

J Am Soc Nephrol. 2015 Oct;26(10):2328-39. doi: 10.1681/ASN.2015020117. Epub 2015 May 12.

Effect of niacin on FGF23 concentration in chronic kidney disease.

Am J Nephrol. 2014;39(6):484-90. doi: 10.1159/000362424. Epub 2014 May 20.

Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease.

Nat Rev Nephrol. 2014 May;10(5):268-78. doi: 10.1038/nrneph.2014.49. Epub 2014 Apr 1.

Phosphate control in end-stage renal disease: barriers and opportunities.

Nephrol Dial Transplant. 2013 Dec;28(12):2961-8. doi: 10.1093/ndt/gft244. Epub 2013 Jul 30.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验